I have been under Dr Verter's care for a couple years after a torn retina. He and his team in Westport have been rockstars! Kudos to all!!! 👏👏👏👏
How Smoking and Lifestyle Choices Affect AMD
Understanding Age-Related Macular Degeneration
AMD is a disease that affects the macula, the small central region of the retina responsible for sharp, detailed vision. Knowing how AMD develops and why early detection matters can help you take the right steps before symptoms appear.
The retina is the light-sensitive tissue lining the back of the eye. The macula sits at its center and handles your most demanding visual tasks, including reading, driving, and recognizing faces. When AMD damages the macula, central vision becomes blurry, distorted, or missing, even while peripheral (side) vision usually stays intact.
AMD is shaped by both genetics and environment. Tens of millions of adults in the United States are living with some stage of this condition, and prevalence increases steadily with age.
AMD takes two main forms. Dry AMD is the more common type. It involves a gradual thinning of the macula, with small yellow deposits called drusen forming beneath the retina. In some people, dry AMD advances to geographic atrophy, a more serious stage in which patches of retinal cells die off and central vision loss becomes more pronounced.
Wet AMD is less common but causes faster and more severe vision loss. It occurs when abnormal blood vessels grow beneath the retina and leak fluid or blood. Without prompt treatment, this can cause rapid damage. AMD always begins in the dry form, and not everyone progresses to the wet form, but both require ongoing monitoring and care.
In its early stages, AMD typically causes no noticeable symptoms. The disease can affect one eye or both without you knowing, and by the time vision changes become apparent, significant damage may already have occurred.
Regular eye exams with a retina specialist are the most reliable way to catch AMD early. Imaging tools such as optical coherence tomography (OCT), a painless scan that captures detailed cross-sections of the retina, can detect changes in the macula long before any symptoms appear.
Why Smoking Is the Leading Modifiable Risk Factor
Among all lifestyle choices that influence AMD, smoking has the strongest and most consistent link to the disease. The body of research on this connection is both extensive and sobering.
Smokers are approximately twice as likely to develop AMD compared with nonsmokers. Current smokers may be up to four times more likely to develop the disease than people who have never smoked. The risk also climbs with the total amount smoked over a lifetime: people with heavy, long-term smoking histories face nearly triple the odds of AMD compared with those who have never smoked.
Timing is also a major concern. Smoking can accelerate the onset of AMD by roughly a decade, meaning smokers may develop the condition around 10 years earlier than they would otherwise.
Cigarette smoke contains thousands of chemicals, many of them highly toxic. When inhaled, these substances enter the bloodstream and reach the delicate tissues of the eye. Because the retina has one of the highest metabolic rates of any tissue in the body, it is especially vulnerable to damage from circulating toxins.
Smoking dramatically increases free radical activity throughout the body. Free radicals are unstable oxygen molecules that damage cells and speed up aging. The retina's exceptional energy demands make it particularly susceptible to this oxidative injury. Over years, this damage compounds quietly, degrading the structures responsible for clear central vision well before any symptoms appear.
The complement cascade is a part of the immune system that helps the body recognize and fight threats. In AMD, this system can become overactivated, triggering inflammation that damages retinal tissue. Cigarette smoke has been shown to trigger this overactivation within the eye.
Genetics also play a role here. People with certain variations in complement-related genes are especially vulnerable to smoke-triggered AMD. Research suggests that smokers with specific genetic profiles may face dramatically higher risks than nonsmokers, and the combination of genetic susceptibility and smoking is thought to account for a meaningful share of all AMD cases.
The macula is partially protected by pigment formed from nutrients called lutein and zeaxanthin. Smoking appears to reduce the body's ability to maintain healthy levels of these protective compounds. Lower macular pigment may leave the retina more exposed to light-related damage and oxidative stress over time.
Smoking also reduces oxygen delivery to the choroid, the layer of tiny blood vessels beneath the retina that supplies it with nutrients and oxygen. When this blood flow is compromised, retinal cells receive less of what they need to stay healthy. This effect accumulates silently over years, accelerating damage long before vision symptoms emerge.
Other Risk Factors That Influence AMD
Smoking is the most significant modifiable risk factor for AMD, but it is not the only one. Several other factors, some within your control and some not, also affect whether AMD develops and how quickly it progresses.
Age is the single strongest overall risk factor for AMD. The likelihood of developing the condition increases steadily after age 55 and rises substantially through the 70s and 80s. A family history of AMD is also highly significant. People with a parent or sibling who has had the disease face meaningfully elevated odds of developing it themselves.
While you cannot change your age or your genetic makeup, knowing your family history is important. It allows you and your retina specialist to plan appropriate screening schedules and respond quickly if early changes appear in the macula.
A high body mass index (BMI) has been associated with increased AMD risk in multiple large studies. Carrying excess weight can promote systemic inflammation and impair vascular health, both of which affect the retina. Regular physical activity, by contrast, appears to have a protective effect.
Moderate exercise supports cardiovascular health, reduces inflammation, and helps maintain healthy blood flow throughout the body, including to the retina. Walking, swimming, and cycling are all practical options. Patients with AMD are often encouraged to incorporate regular physical activity as part of a broader strategy for protecting their vision.
A diet rich in antioxidants, healthy fats, and specific vitamins appears to support retinal health and may help slow AMD progression. Nutrients that have received the most research attention include lutein, zeaxanthin, vitamins C and E, zinc, and omega-3 fatty acids.
Good dietary sources include dark leafy greens such as spinach and kale, colorful fruits and vegetables, fatty fish like salmon and sardines, and nuts and seeds. Research from the Age-Related Eye Disease Studies (AREDS and AREDS2) found that specific supplement formulations can reduce the risk of progression from intermediate to advanced AMD. Talk with your retina specialist before starting any supplement, as not every formulation is appropriate for every patient.
High blood pressure (hypertension) is a recognized risk factor for AMD. The blood vessels in and around the retina are sensitive to elevated pressure, and chronically high blood pressure can damage them over time, contributing to AMD progression.
Keeping blood pressure within a healthy range through diet, exercise, and medication when prescribed by your physician is one of the most practical ways to protect retinal health. Maintaining healthy cholesterol and blood sugar levels matters as well, since overall vascular health affects how well the eye is nourished and maintained.
Even if you do not smoke, regular exposure to secondhand smoke carries real risk. Research shows an elevated risk of AMD in nonsmokers who are chronically exposed to other people's cigarette smoke. The toxic compounds in cigarette smoke do not only affect the person actively smoking.
Reducing secondhand smoke exposure in the home, car, or workplace is a meaningful step toward lowering AMD risk. If someone in your household smokes, encouraging them to seek support for quitting benefits both of you.
How Smoking Affects AMD Treatment
Smoking does not only increase the risk of developing AMD. It also makes the disease harder to treat and more likely to progress even when care is underway.
Research has found that smokers are significantly more likely to have a poor response to intravitreal therapy, which refers to injections of medication delivered directly into the eye. In one study, smokers faced a roughly seven-fold higher risk of a poor treatment outcome compared with nonsmokers. If you already have AMD, continuing to smoke can accelerate disease progression and reduce the benefit you receive from treatment.
Anti-VEGF medications are the primary treatment for wet AMD. VEGF, or vascular endothelial growth factor, is a protein that drives the growth of abnormal blood vessels beneath the retina. Anti-VEGF drugs block this process and are delivered by intravitreal injection. Approved options in this category include the following.
- Aflibercept (Eylea): typically given every 4 to 8 weeks after an initial loading phase
- Ranibizumab (Lucentis): given approximately every 4 weeks
- Faricimab (Vabysmo): a bispecific antibody targeting both VEGF and a second protein called Ang-2, given every 4 to 16 weeks
- Bevacizumab (Avastin): used off-label for wet AMD, given every 4 to 6 weeks
- High-dose aflibercept (Eylea HD): allows extended dosing intervals of 8 to 16 weeks after the loading phase
Anti-VEGF treatment improves vision in roughly one in three patients and stabilizes vision in approximately nine out of ten. These remain the first-line therapies for wet AMD. However, a meaningful percentage of patients do not achieve an optimal response, which is one more reason why lifestyle factors and early prevention matter alongside medical treatment.
Geographic atrophy is the advanced form of dry AMD. It involves a separate disease process from wet AMD and requires different treatments. Two complement inhibitor medications are now FDA-approved specifically to slow the growth of geographic atrophy lesions by targeting overactivation of the immune complement system.
Pegcetacoplan (Syfovre), a C3 complement inhibitor, is given monthly or every other month. Avacincaptad pegol (Izervay), a C5 complement inhibitor, is given monthly. These medications slow the rate of retinal cell loss but cannot restore vision that has already been lost. For earlier stages of dry AMD, no drug currently reverses the condition, which makes preventing progression through lifestyle choices all the more important.
Steps You Can Take to Protect Your Vision
Many of the most effective strategies for reducing AMD risk and slowing its progression are within your control. These steps carry the most benefit when started early, but beginning at any stage can make a meaningful difference.
Quitting smoking is the single most impactful lifestyle change you can make for AMD risk. Benefits begin from the moment you stop. While it takes time for your risk to decline significantly, every smoke-free day reduces ongoing oxidative and vascular damage to the retina.
Talk with your primary care physician about cessation support, including counseling programs, nicotine replacement therapy, and prescription medications designed to help you quit. Your retina specialist can reinforce this goal and explain how quitting may improve your response to treatment if you are already receiving care for AMD.
A diet that actively supports the macula is built around foods rich in key protective nutrients. Practical choices that make a real difference include the following.
- Dark leafy greens such as spinach, kale, and collard greens, which are high in lutein and zeaxanthin
- Colorful fruits and vegetables including bell peppers, oranges, and berries for vitamins C and E
- Fatty fish such as salmon, mackerel, and sardines for omega-3 fatty acids
- Nuts, seeds, and whole grains for zinc and other trace nutrients that support eye health
For patients with intermediate AMD, AREDS2-formula supplements have been shown to reduce the risk of progression to advanced AMD. Ask your retina specialist whether this formulation is appropriate for your specific situation before starting any supplement.
Aiming for at least 150 minutes of moderate-intensity exercise per week offers meaningful benefits for eye health. Regular activity improves blood flow, reduces systemic inflammation, and helps control weight and blood pressure, all of which influence AMD risk. Walking, swimming, and cycling are practical options that most people can sustain over time.
Work with your primary care physician to keep blood pressure, cholesterol, and blood sugar within healthy ranges. These conditions affect the blood vessels that nourish the retina. Be sure to share your complete health and eye history with your retina specialist, including any previous cataract surgery, which has been associated with a modestly elevated AMD risk in some research.
Because AMD often causes no symptoms in its early stages, routine comprehensive eye exams are essential for detecting it before vision loss occurs. If you are over 50, have a family history of AMD, or have risk factors such as a history of smoking, a retina specialist can perform detailed macula imaging before you notice any changes in your vision. Early detection is one of the most effective tools available for preserving long-term sight.
When to See a Retina Specialist
Knowing when to schedule a routine visit and when to seek urgent care is an important part of protecting your vision at every stage of AMD.
If you have been diagnosed with early or intermediate AMD, regular visits with a retina specialist are essential for tracking any changes. These appointments typically include dilated eye exams and OCT imaging to monitor the macula over time. How often you are seen depends on your individual situation and current stage of disease.
Some symptoms require immediate attention. If you notice any of the following, contact a retina specialist or seek emergency eye care right away, as prompt treatment can significantly affect your outcome.
- A sudden increase in floaters (spots, strings, or shapes drifting across your vision)
- Flashes of light in one or both eyes
- A dark curtain or shadow blocking part of your field of vision
- Sudden or rapid loss of vision in one eye
- Straight lines appearing wavy or distorted (a symptom called metamorphopsia)
These symptoms can indicate a retinal tear, a detachment, or a rapid transition from dry to wet AMD. Acting quickly in these situations can make a significant difference in preserving vision.
If you currently smoke and have been diagnosed with any stage of AMD, please discuss quitting with both your retina specialist and your primary care provider. Continuing to smoke accelerates disease progression and reduces how well your eyes respond to treatment. Taking action now, rather than waiting for symptoms to worsen, gives your vision the best chance of remaining as stable as possible.
Frequently Asked Questions
Below are answers to common questions we hear from patients about AMD, smoking, and how lifestyle choices affect their care and treatment decisions.
Risk begins to decrease as soon as you stop smoking, though it does not drop immediately to the level of someone who has never smoked. Former smokers carry a higher risk than lifelong nonsmokers for several years after quitting, but that risk is measurably lower than for people who continue to smoke. The decline is gradual, and each year without cigarettes allows the body to begin recovering from some of the oxidative and vascular damage smoking caused. The sooner you quit, the greater the potential long-term benefit to your retinal health.
Yes, though no lifestyle change can reverse existing damage. Quitting smoking, improving your diet, exercising regularly, and managing blood pressure and cholesterol can all help slow the rate of progression. For patients with intermediate dry AMD, AREDS2 supplement formulations may provide added protection against advancement to a more severe stage. Always discuss any planned changes to your diet, exercise routine, or supplement regimen with your retina specialist so your care plan can reflect your complete picture.
Yes. Research shows an elevated risk of AMD in nonsmokers who are regularly exposed to secondhand smoke. The toxic compounds in cigarette smoke do not only affect the person holding the cigarette. People who share a home or frequently spend time in enclosed spaces where others smoke may face elevated risk through chronic exposure. Practical steps include eliminating indoor smoking in your home and, where possible, encouraging those around you to seek cessation support.
There is not yet enough long-term research to confirm whether e-cigarettes carry the same AMD risk as traditional cigarettes. However, vaping still delivers nicotine and other chemicals that can affect blood vessel health and oxidative stress throughout the eye. Until more data are available, vaping should not be considered a safe alternative when it comes to protecting your retinal health. If you are using e-cigarettes as a quitting strategy, work with your physician on a clear plan to eliminate them as well.
AREDS2 supplements were studied primarily in patients with intermediate AMD or advanced AMD in one eye. Evidence for meaningful benefit in early-stage disease is less established, and not every patient at this stage will need them. The right decision depends on your specific stage of disease, your current diet, and other individual health factors. Your retina specialist is best positioned to help you determine whether these supplements are appropriate for you, since taking the wrong formulation or an unnecessary supplement carries its own considerations.
AMD can behave differently in each eye, and treatment is always individualized. If one eye has advanced AMD while the other shows only early or intermediate disease, your retina specialist will monitor both closely, because the less-affected eye faces a real risk of progression over time. In some situations, treatment may be given to one eye while the other is carefully observed. Maintaining your scheduled monitoring visits matters even when one eye feels stable, as early changes are always easier to address when caught promptly.
Visit New England Retina Associates for Expert Retina Care
At New England Retina Associates, our fellowship-trained retina specialists bring deep expertise to diagnosing and managing AMD at every stage, and we are proud to serve patients across our Connecticut locations. Whether you are newly referred, monitoring a known diagnosis, or experiencing symptoms for the first time, our team is here to provide thorough, compassionate care. We welcome self-referred patients and are prepared to evaluate urgent concerns promptly, so please reach out and take the next step toward protecting your vision.
30 Years of Care & Commitment
